跳至主要内容
临床试验/ITMCTR2022000046
ITMCTR2022000046尚未招募1 期

Study on the intervention and management model of metabolic syndrome complicated with hyperuricemia based on ''state'' identification --Study on comprehensive intervention in acute stage of metabolic syndrome complicated with gout

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria of gouty arthritis and metabolic syndrome in western medicine; (2) It conforms to the standard of dampness heat stasis syndrome in TCM; (3) Acute course of disease, the time from this attack to treatment is within 1 week; (4) The patient is over 18 years old; (5) After full notification, the patient is willing to cooperate with relevant diagnosis and treatment and sign the informed consent.

排除标准

  • (1) Secondary hyperuricemia and Gout Caused by some systemic diseases or drugs, such as myeloproliferative diseases and gouty arthritis caused by diuretics; (2) The patient's affected joints were complicated with serious fracture, trauma, traumatic arthritis and other diseases, which affected the curative effect; (3) Gout has caused severe deformity of affected joints or skin ulceration, affecting the functional judgment and external drug users; (4) The patient has received or is receiving uric acid lowering treatment, such as oral febusitar, benzbromarone, allopurinol and other drugs; (5) Patients who are known to be allergic or intolerant to the drugs used for treatment; (6) Patients with severe cardiovascular, cerebrovascular, blood system, immune system, mental system and other diseases, liver and kidney dysfunction.

研究者

发起方
Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

相似试验